Calls For COVID Patent Waivers Persist As Pooling Initiatives Plough Ahead
Patents On COVID-19 Therapeutics Have Been Accused Of Impeding International Access
The formulas for various COVID-19 vaccines remain shrouded in intellectual property protections – one of many factors preventing them from being manufactured in developing nations. Those in favor of upholding IP say that scrapping patents could stifle future innovation, but their opponents believe preserving COVID-19 related IP rights is limiting access to lifesaving medical tools.
